LUPIN LTD 2017-18 Annual Report Analysis

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD 2017-18 Annual Report Analysis
Thu, 16 Aug

LUPIN LTD has announced its results for the year ended March 2018. Let us have a look at the detailed performance review of the company during FY17-18.

LUPIN LTD Income Statement Analysis

  • Operating income during the year fell 9.7% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 29.9% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 19.9% in FY18 as against 25.7% in FY17.
  • Depreciation charges and finance costs increased by 19.0% YoY and 34.0% YoY, respectively.
  • Other income grew by 41.2% YoY.
  • Net profit for the year declined by 90.2% YoY.
  • Net profit margins during the year declined from 14.5% in FY17 to 1.6% in FY18.

LUPIN LTD Income Statement 2017-18

No. of Mths Year Ending 12 Mar-17* 12 Mar-18* % Change
Net Sales Rs m 174,943 158,042 -9.7%
Other income Rs m 1,065 1,504 41.2%
Total Revenues Rs m 176,008 159,545 -9.4%
Gross profit Rs m 44,931 31,475 -29.9%
Depreciation Rs m 9,122 10,859 19.0%
Interest Rs m 1,525 2,044 34.0%
Profit before tax Rs m 35,349 20,076 -43.2%
Tax Rs m 9,785 2,885 -70.5%
Profit after tax Rs m 25,575 2,513 -90.2%
Gross profit margin % 25.7 19.9
Effective tax rate % 27.7 14.4
Net profit margin % 14.5 1.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



LUPIN LTD Balance Sheet Analysis

  • The company's current liabilities during FY18 down at Rs 51 billion as compared to Rs 61 billion in FY17, thereby witnessing an decrease of -16.7%.
  • Long-term debt stood at Rs 64 billion as compared to Rs 56 billion during FY17, a growth of 13.8%.
  • Current assets rose 2% and stood at Rs 122 billion, while fixed assets fell 1% and stood at Rs 130 billion in FY18.
  • Overall, the total assets and liabilities for FY18 stood at Rs 263 billion as against Rs 266 billion during FY17, thereby witnessing a fall of 1%.

LUPIN LTD Balance Sheet as on March 2018

No. of Mths Year Ending 12 Mar-17* 12 Mar-18* % Change
Networth Rs m 134,976 135,771 0.6
 
Current Liabilities Rs m 61,206 50,956 -16.7
Long-term Debt Rs m 56,478 64,245 13.8
Total Liabilities Rs m 266,073 263,054 -1.1
 
Current assets Rs m 119,529 122,095 2.1
Fixed Assets Rs m 131,660 129,876 -1.4
Total Assets Rs m 266,073 263,054 -1.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



LUPIN LTD Cash Flow Statement Analysis

  • LUPIN LTD's cash flow from operating activities (CFO) during FY18 stood at Rs 18 billion on a YoY basis.
  • Cash flow from investing activities (CFI) during FY18 stood at Rs -14 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during FY18 stood at Rs -15 billion on a YoY basis.
  • Overall, net cash flows for the company during FY18 stood at Rs -11 billion from the Rs 20 billion net cash flows seen during FY17.

LUPIN LTD Cash Flow Statement 2017-18

Particulars No. of months 12 12 % Change
Year Ending Mar-17 Mar-18
Cash Flow from Operating Activities Rs m 41,135 17,512 -57.4%
Cash Flow from Investing Activities Rs m -25,274 -14,073 -
Cash Flow from Financing Activities Rs m 4,332 -14,921 -
Net Cash Flow Rs m 20,193 -11,482 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Current Valuations for LUPIN LTD

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 5.6, an decline from the EPS of Rs 56.6 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 850.6, stands at 27.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.6 times, while the price to sales ratio stands at 3.1 times.
  • The company's price to cash flow (P/CF) ratio stood at 28.6 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-17* 12 Mar-18*
Sales per share (Unadj.) Rs 387.4 349.6
TTM Earnings per share Rs 56.6 5.6
Diluted earnings per share Rs 56.7 5.6
Price to Cash Flow x 11.1 28.6
TTM P/E ratio x 27.0 27.0
Price / Book Value ratio x 5.2 3.6
Market Cap Rs m 384,114 383,739
Dividends per share (Unadj.) Rs 7.5 5.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Ratio Analysis for LUPIN LTD

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 2.4x during FY18, from 2.0x during FY17. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 10.8x during FY18, from 24.2x during FY17. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 1.9% during FY18, from 18.9% during FY18. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 3.7% during FY18, from 19.3% during FY17. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 1.7% during FY18, from 10.2% during FY17. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-17* 12 Mar-18*
Current ratio x 2.0 2.4
Debtors’ Days Days 90 120
Interest coverage x 24.2 10.8
Debt to equity ratio x 0.4 0.5
Return on assets % 10.2 1.7
Return on equity % 18.9 1.9
Return on capital employed % 19.3 3.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



To see how LUPIN LTD has performed over the last 5 years, please visit here.

LUPIN LTD Share Price Performance

Over the last one year, LUPIN LTD share price has moved up from Rs 962.2 to Rs 850.6, registering a loss of Rs 111.6 or around 11.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,832.7 (up 1.0%). Over the last one year it has moved up from 13,214.8 to 14,832.7, a gain of 1,618 points (up 12.2%).

Overall, the S&P BSE SENSEX is up 19.8% over the year.

(To know more, check out historical annual results for LUPIN LTD and quarterly results for LUPIN LTD)

Equitymaster requests your view! Post a comment on "LUPIN LTD 2017-18 Annual Report Analysis". Click here!

  

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS